Carregant...
A sting in the tail: the N-terminal domain of the androgen receptor as a drug target
The role of androgen receptor (AR) in the initiation and progression of prostate cancer (PCa) is well established. Competitive inhibition of the AR ligand-binding domain (LBD) has been the staple of antiandrogen therapies employed to combat the disease in recent years. However, their efficacy has of...
Guardat en:
| Publicat a: | Asian J Androl |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5000789/ https://ncbi.nlm.nih.gov/pubmed/27212126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.181081 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|